Discovery MI Gen2
Description
The Discovery MI Gen2 PET/CT system is intended for CT attenuation corrected, anatomically localized PET imaging of the distribution of positron-emitting radiopharmaceuticals. It is intended to image the whole body, head, heart, brain, lung, breast, bone, the gastrointestinal and lymphatic systems, and other organs. The system is also intended for stand-alone, diagnostic CT imaging.
Detailed example
Produces attenuation corrected PET images.
AI / analytics pattern
Computer Vision: AI that processes and interprets visual data (e.g., images and videos).
Automation level / stage
c) Deployed – The use case is being actively authorized or utilized to support the functions or mission of an agency.
Expected benefit
The introduction of the 30 cm configuration comes with several clinical benefits. Compared to other Discovery MI configurations, the higher AFOV coverage allows a patient to be scanned using fewer field of views and can result in scanning in shorter time. Additionally, sensitivity of the 30 cm system is higher compared to other configurations, like the Discovery MI 25 cm, which assists in dose reduction and better detectability of small lesions.
Controls / human review
ATO: Not reported; PIA: Not published